Stay updated with the latest t-cell news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on t-cell topics.
Mumbai: Dr Reddy's Laboratories has entered into a collaboration with Reykjavik, Ireland-based biotech company Alvotech to co-develop, manufacture and commercialise a biosimilar version of blockbuster cancer drug Keytruda for the global markets. Keytruda (generic name is pembrolizumab), manufactured and marketed by Merck & Co, is the most successful medicine, recording worldwide sales of $29.5 billion in 2024. It is used to treat multiple forms of cancer. Under the terms of the agreement, both ...Read More >
VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement offering (the "Offering") consisting of up to an aggregate of 14,285,715 units of the Company (each, a "Unit") at a price of CAD$0.07 per Unit for gross proceeds of up to CAD$1,000,000. Each Unit consists of one (1) common share in the capital of the Company (each, a "Share") and one (1) wh ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.